Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its outstanding common stock. The program has no time limit and can be discontinued at any time.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
973.2 USD | -1.20% | -2.09% | +10.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.80% | 106B | |
+9.83% | 118B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B | |
-30.73% | 7.55B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of its shares.